Last updated on December 2019

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Nonradiographic Axial Spondyloarthritis

Brief description of study

The purpose of the study is to demonstrate the efficacy, safety and tolerability of bimekizumab administered subcutaneously (sc) compared to placebo in the treatment of subjects with active nonradiographic axial spondyloarthritis (nr-axSpA).

Clinical Study Identifier: NCT03928704

Find a site near you

Start Over

As0010 20032

Suita, Japan
  Connect »

As0010 20037

Osaka, Japan
  Connect »